Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
I found something strange on my back – and eventually I just couldn’t ignore it | Adrian Chiles
5/11/2025
Louvre heist suspect is social media star and former museum guard, reports say
5/11/2025
More reading tests won’t help children improve their literacy – here’s what will | Letters
5/11/2025
Tackling the democracy deficit in schools | Letter
5/11/2025
End-of-life care needs a fundamental review, not just more funding | Letters
5/11/2025
We need to restore Britain’s connection to nature | Letter
5/11/2025